FTC challenges ‘junk’ drug patents. Here’s what they are and why they matter

FTC challenges 'junk' drug patents.  Here's what they are and why they matter

The US Federal Trade Commission (FTC) announced last week that, for the second time, dispute hundreds of rubbish patents listed in the Food and Drug Administrations (FDA) Orange Book, a …

Read more

These lifestyle gyms aren’t competing with Ozempic, they’re embracing it

These lifestyle gyms aren't competing with Ozempic, they're embracing it

You might think that a class of drugs that have been proven to help users lose weight 15% to 20% of your body weight can put the fitness industry on …

Read more